Stay updated on Abaloparatide Long-Term Extension Clinical Trial
Sign up to get notified when there's something new on the Abaloparatide Long-Term Extension Clinical Trial page.

Latest updates to the Abaloparatide Long-Term Extension Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe clinical trial record for the ACTIVExtend osteoporosis study is displayed, with details on its alendronate treatment, participants, study outcomes, and locations.SummaryDifference51%

- Check16 days agoChange DetectedThe site footer’s revision identifier changed from v3.7.2 to v3.8.0. The study record remains inaccessible on the 403 error page.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide NIH notice announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check30 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe site revision displayed in the footer changed from v3.7.0 to v3.7.1, while the study page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study record for NCT01657162 now renders a 403 Forbidden error, replacing the former content and navigation. This makes the page inaccessible and blocks viewing the study details.SummaryDifference17%

Stay in the know with updates to Abaloparatide Long-Term Extension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abaloparatide Long-Term Extension Clinical Trial page.